|
1
|
Li D, Zhang J, Li X, Chen Y, Yu F and Liu
Q: Insights into lncRNAs in Alzheimer's disease mechanisms. RNA
Biol. 18:1037–1047. 2021. View Article : Google Scholar
|
|
2
|
Zhu L, Li N, Sun L, Zheng D and Shao G:
Non-coding RNAs: The key detectors and regulators in cardiovascular
disease. Genomics. 113:1233–1246. 2021. View Article : Google Scholar
|
|
3
|
Lu Q, Guo P, Liu A, Ares I,
Martínez-Larrañaga MR, Wang X, Anadón A and Martínez MA: The role
of long noncoding RNA in lipid, cholesterol, and glucose metabolism
and treatment of obesity syndrome. Med Res Rev. 41:1751–1774. 2021.
View Article : Google Scholar
|
|
4
|
Ferlita A, Battaglia R, Andronico F,
Caruso S, Cianci A, Purrello M and Pietro CD: Non-coding RNAs in
endometrial physiopathology. Int J Mol Sci. 19:21202018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Statello L, Guo CJ, Chen LL and Huarte M:
Gene regulation by long non-coding RNAs and its biological
functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar
|
|
6
|
Bin X, Hongjian Y, Xiping Z, Bo C, Shifeng
Y and Binbin T: Research progresses in roles of LncRNA and its
relationships with breast cancer. Cancer Cell Int. 18:1792018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liau WS, Samaddar S, Banerjee S and Bredy
TW: On the functional relevance of spatiotemporally-specific
patterns of experience-dependent long noncoding RNA expression in
the brain. RNA Biol. 18:1025–1036. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yarani R, Mirza AH, Kaur S and Pociot F:
The emerging role of lncRNAs in inflammatory bowel disease. Exp Mol
Med. 50:1–14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng H, Wan LY, Liang JJ, Zhang YQ, Ai WB
and Wu JF: The roles of lncRNA in hepatic fibrosis. Cell Biosci.
8:632018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jantrapirom S, Koonrungsesomboon N,
Yoshida H, M Candeias M, Pruksakorn D and Lo Piccolo L: Long
noncoding RNA-dependent methylation of nonhistone proteins. Wiley
Interdiscip Rev RNA. 12:e16612021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khalili-Tanha G and Moghbeli M: Long
non-coding RNAs as the critical regulators of doxorubicin
resistance in tumor cells. Cell Mol Biol Lett. 26:392021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li N, Zhang H, Hu K and Chu J: A novel
long non-coding RNA-based prognostic signature for renal cell
carcinoma patients with stage IV and histological grade G4.
Bioengineered. 12:6275–6285. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bo C, Li N, He L, Zhang S and An Y: Long
non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma
progression by stabilizing ILF3 mRNA in an m6A-dependent
manner. Hum Cell. 34:1843–1854. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo Y, Ge P, Wang M and Chen H, Liu J, Wei
T, Jiang Y, Qu J and Chen H: Research progress of DLX6-AS1 in human
cancers. Hum Cell. 34:1642–1652. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma L, Bajic VB and Zhang Z: On the
classification of long non-coding RNAs. RNA Biol. 10:925–933. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bhatti GK, Khullar N, Sidhu IS, Navik US,
Reddy AP, Reddy PH and Bhatti JS: Emerging role of non-coding RNA
in health and disease. Metab Brain Dis. 36:1119–1134. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nojima T and Proudfoot NJ: Mechanisms of
lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev
Mol Cell Biol. 23:389–406. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan W, Hu H and Tang B: Progress in
understanding the relationship between long noncoding RNA and
endometriosis. Eur J Obstet Gynecol Reprod Biol X. 5:1000672019.
View Article : Google Scholar
|
|
20
|
Constanty F and Shkumatava A: lncRNAs in
development and differentiation: From sequence motifs to functional
characterization. Development. 148:dev1827412021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Bian C, Tu S, Yin F, Guo P, Zhang
J, Song X, Liu Q, Chen C and Han Y: Integrated analysis of
lncRNA-miRNA-mRNA ceRNA network in human aortic dissection. BMC
Genomics. 22:7242021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Qian Y, Zhang C, Wang W, Qiao Y,
Song H, Li L, Guo J, Lu D and Deng X: LncRNA LINC00473 is involved
in the progression of invasive pituitary adenoma by upregulating
KMT5A via ceRNA-mediated miR-502-3p evasion. Cell Death Dis.
12:5802021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Irwin AB, Bahabry R and Lubin FD: A
putative role for lncRNAs in epigenetic regulation of memory.
Neurochem Int. 150:1051842021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen X, Xie R, Gu P, Huang M, Han J, Dong
W, Xie W, Wang B, He W, Zhong G, et al: Long noncoding RNA LBCS
inhibits self-renewal and chemoresistance of bladder cancer stem
cells through epigenetic silencing of SOX2. Clin Cancer Res.
25:1389–1403. 2019. View Article : Google Scholar
|
|
25
|
Wang D, Sun Y, Lin L, Sang Y, Yang F,
Zhang J, Jia L, Xu Z and Zhang W: Long non-coding RNA H19 and the
underlying epigenetic function in response to DNA damage of lung
cancer cells. Am J Transl Res. 13:5835–5850. 2021.PubMed/NCBI
|
|
26
|
Hernández-Aguilar AI, Luciano-Villa CA,
Tello-Flores VA, Beltrán-Anaya FO, Zubillaga-Guerrero MI and
Flores-Alfaro E: Dysregulation of lncRNA-H19 in cardiometabolic
diseases and the molecular mechanism involved: A systematic review.
Expert Rev Mol Diagn. 21:809–821. 2021. View Article : Google Scholar
|
|
27
|
Matsuzaki H, Okamura E, Takahashi T,
Ushiki A, Nakamura T, Nakano T, Hata K, Fukamizu A and Tanimoto K:
De novo DNA methylation through the 5′-segment of the H19 ICR
maintains its imprint during early embryogenesis. Development.
142:3833–3844. 2015.PubMed/NCBI
|
|
28
|
Gabory A, Jammes H and Dandolo L: The H19
locus: role of an imprinted non-coding RNA in growth and
development. Bioessays. 32:473–480. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Sun J and Yang F: The role of long
non-coding RNA H19 in breast cancer. Oncol Lett. 19:7–16.
2020.PubMed/NCBI
|
|
30
|
Wang Y and Gao WJ: Long non-coding RNA-H19
promotes ovarian cancer cell proliferation and migration via the
microRNA-140/Wnt1 axis. Kaohsiung J Med Sci. 37:768–775. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Zhang Y, Hu Q, Egranov SD, Xing Z,
Zhang Z, Liang K, Ye Y, Pan Y, Chatterjee SS, et al: Functional
significance of gain-of-function H19 lncRNA in skeletal muscle
differentiation and anti-obesity effects. Genome Med. 13:1372021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L and Qi L: The role and mechanism of
long non-coding RNA H19 in stem cell osteogenic differentiation.
Mol Med. 27:862021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Su W, Huo Q, Wu H, Wang L, Ding X, Liang
L, Zhou L, Zhao Y, Dan J and Zhang H: The function of LncRNA-H19 in
cardiac hypertrophy. Cell Biosci. 11:1532021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tian X, Wang Y, Lu Y, Wang W, Du J, Chen
S, Zhou H, Cai W and Xiao Y: Conditional depletion of macrophages
ameliorates cholestatic liver injury and fibrosis via lncRNA-H19.
Cell Death Dis. 12:6462021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghafouri-Fard S, Esmaeili M and Taheri M:
H19 lncRNA: Roles in tumorigenesis. Biomed Pharmacother.
123:1097742020. View Article : Google Scholar
|
|
36
|
Yang J, Qi M, Fei X, Wang X and Wang K:
LncRNA H19: A novel oncogene in multiple cancers. Int J Biol Sci.
17:3188–3208. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shermane Lim YW, Xiang X, Garg M, Le MT,
Li-Ann Wong A, Wang L and Goh BC: The double-edged sword of H19
lncRNA: Insights into cancer therapy. Cancer Lett. 500:253–262.
2021. View Article : Google Scholar
|
|
38
|
Wei LQ, Li L, Lu C, Liu J, Chen Y and Wu
H: Involvement of H19/miR-326 axis in hepatocellular carcinoma
development through modulating TWIST1. J Cell Physiol.
234:5153–5162. 2019. View Article : Google Scholar
|
|
39
|
Ye Y, Guo J, Xiao P, Ning J, Zhang R, Liu
P, Yu W, Xu L, Zhao Y and Yu J: Macrophages-induced long noncoding
RNA H19 up-regulation triggers and activates the miR-193b/MAPK1
axis and promotes cell aggressiveness in hepatocellular carcinoma.
Cancer Lett. 469:310–322. 2020. View Article : Google Scholar
|
|
40
|
Li CF, Li YC, Wang Y and Sun LB: The
effect of LncRNA H19/miR-194-5p axis on the epithelial-mesenchymal
transition of colorectal adenocarcinoma. Cell Physiol Biochem.
50:196–213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ding D, Li C, Zhao T, Li D, Yang L and
Zhang B: LncRNA H19/miR-29b-3p/PGRN axis promoted
epithelial-mesenchymal transition of colorectal cancer cells by
acting on Wnt signaling. Mol Cells. 41:423–435. 2018.PubMed/NCBI
|
|
42
|
Chen S, Bu D, Ma Y, Zhu J, Chen G, Sun L,
Zuo S, Li T, Pan Y, Wang X, et al: H19 overexpression induces
resistance to 1,25(OH)2D3 by targeting VDR through miR-675-5p in
colon cancer cells. Neoplasia. 19:226–236. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lv M, Zhong Z, Huang M, Tian Q, Jiang R
and Chen J: lncRNA H19 regulates epithelial-mesenchymal transition
and metastasis of bladder cancer by miR-29b-3p as competing
endogenous RNA. Biochim Biophys Acta Mol Cell Res. 1864:1887–1899.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xiong H, Shen J, Chen Z, Yang J, Xie B,
Jia Y, Jayasinghe U, Wang J, Zhao W, Xie S, et al: H19/let-7/Lin28
ceRNA network mediates autophagy inhibiting epithelial-mesenchymal
transition in breast cancer. Int J Oncol. 56:794–806.
2020.PubMed/NCBI
|
|
45
|
Zhao W, Lin X, Han H, Zhang H, Li X, Jiang
C and Feng M: Long noncoding RNA H19 contributes to the
proliferation and autophagy of glioma cells through mTOR/ULK1
pathway. Neuroreport. 32:352–358. 2021.PubMed/NCBI
|
|
46
|
Luan W, Zhou Z, Ni X, Xia Y, Wang J, Yan Y
and Xu B: Long non-coding RNA H19 promotes glucose metabolism and
cell growth in malignant melanoma via miR-106a-5p/E2F3 axis. J
Cancer Res Clin Oncol. 144:531–542. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zheng ZH, Wu DM, Fan SH, Zhang ZF, Chen GQ
and Lu J: Upregulation of miR-675-5p induced by lncRNA H19 was
associated with tumor progression and development by targeting
tumor suppressor p53 in non-small cell lung cancer. J Cell Biochem.
120:18724–18735. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sun L, Li J, Yan W, Yao Z, Wang R, Zhou X,
Wu H, Zhang G, Shi T and Chen W: H19 promotes aerobic glycolysis,
proliferation, and immune escape of gastric cancer cells through
the microRNA-519d-3p/lactate dehydrogenase A axis. Cancer Sci.
112:2245–2259. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
He H, Wang N, Yi X, Tang C and Wang D:
Long non-coding RNA H19 regulates E2F1 expression by competitively
sponging endogenous miR-29a-3p in clear cell renal cell carcinoma.
Cell Biosci. 7:652017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhao TF, Jia HZ, Zhang ZZ, Zhao XS, Zou
YF, Zhang W, Wan J and Chen XF: LncRNA H19 regulates ID2 expression
through competitive binding to hsa-miR-19a/b in acute myelocytic
leukemia. Mol Med Rep. 16:3687–3693. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sun Y, Zhu Q, Yang W, Shan Y, Yu Z, Zhang
Q and Wu H: LncRNA H19/miR-194/PFTK1 axis modulates the cell
proliferation and migration of pancreatic cancer. J Cell Biochem.
120:3874–3886. 2019. View Article : Google Scholar
|
|
52
|
Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng
R, Wang Y, Huang J, Xu M, Yan J and Yu J: lncRNA H19/miR-675 axis
represses prostate cancer metastasis by targeting TGFBI. FEBS J.
281:3766–3775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou
WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation
of the MiR-200 family contributes to H19-mediated metastasis
suppression in hepatocellular carcinoma. Carcinogenesis.
34:577–586. 2013. View Article : Google Scholar
|
|
54
|
Fang Y, Hu J, Wang Z, Zong H, Zhang L,
Zhang R and Sun L: LncRNA H19 functions as an aquaporin 1
competitive endogenous RNA to regulate microRNA-874 expression in
LPS sepsis. Biomed Pharmacother. 105:1183–1191. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lu Q, Guo Z, Xie W, Jin W, Zhu D, Chen S
and Ren T: The lncRNA H19 mediates pulmonary fibrosis by regulating
the miR-196a/COL1A1 axis. Inflammation. 41:896–903. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Song Y, Liu C, Liu X, Trottier J, Beaudoin
M, Zhang L, Pope C, Peng G, Barbier O, Zhong X, et al: H19 promotes
cholestatic liver fibrosis by preventing ZEB1-mediated inhibition
of epithelial cell adhesion molecule. Hepatology. 66:1183–1196.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
You L, Lv Z, Li C, Ye W, Zhou Y, Jin J and
Han Q: Worldwide cancer statistics of adolescents and young adults
in 2019: A systematic analysis of the global burden of disease
study 2019. ESMO Open. 6:1002552021. View Article : Google Scholar
|
|
58
|
Hoppe-Seyler F and Hoppe-Seyler K:
Emerging topics in human tumor virology. Int J Cancer.
129:1289–1299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Gibb EA, Becker-Santos DD, Enfield KS,
Guillaud M, Niekerk Dv, Matisic JP, Macaulay CE and Lam WL:
Aberrant expression of long noncoding RNAs in cervical
intraepithelial neoplasia. Int J Gynecol Cancer. 22:1557–1563.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhong Q, Lu M, Yuan W, Cui Y, Ouyang H,
Fan Y, Wang Z, Wu C, Qiao J and Hang J: Eight-lncRNA signature of
cervical cancer were identified by integrating DNA methylation,
copy number variation and transcriptome data. J Transl Med.
19:582021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kim SJ, Park SE, Lee C, Lee SY, Jo JH, Kim
JM and Oh YK: Alterations in promoter usage and expression levels
of insulin-like growth factor-II and H19 genes in cervical
carcinoma exhibiting biallelic expression of IGF-II. Biochim
Biophys Acta. 1586:307–315. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Iempridee T: Long non-coding RNA H19
enhances cell proliferation and anchorage-independent growth of
cervical cancer cell lines. Exp Biol Med (Maywood). 242:184–193.
2017. View Article : Google Scholar
|
|
63
|
Ou L, Wang D, Zhang H, Yu Q and Hua F:
Decreased expression of miR-138-5p by lncRNA H19 in cervical cancer
promotes tumor proliferation. Oncol Res. 26:401–410. 2018.
View Article : Google Scholar
|
|
64
|
Peng L, Yuan XQ, Liu ZY, Li WL, Zhang CY,
Zhang YQ, Pan X, Chen J, Li YH and Li GC: High lncRNA H19
expression as prognostic indicator: Data mining in female cancers
and polling analysis in non-female cancers. Oncotarget.
8:1655–1667. 2017. View Article : Google Scholar :
|
|
65
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Takenaka K, Chen BJ, Modesitt SC, Byrne
FL, Hoehn KL and Janitz M: The emerging role of long non-coding
RNAs in endometrial cancer. Cancer Genet. 209:445–455. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Urick ME and Bell DW: Clinical
actionability of molecular targets in endometrial cancer. Nat Rev
Cancer. 19:510–521. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Brooks RA, Fleming GF, Lastra RR, Lee NK,
Moroney JW, Son CH, Tatebe K and Veneris JL: Current
recommendations and recent progress in endometrial cancer. CA
Cancer J Clin. 69:258–279. 2019.PubMed/NCBI
|
|
69
|
Xu J, Qian Y, Ye M, Fu Z, Jia X, Li W, Xu
P, Lv M, Huang L, Wang L, et al: Distinct expression profile of
lncRNA in endometrial carcinoma. Oncol Rep. 36:3405–3412. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Smolle MA, Bullock MD, Ling H, Pichler M
and Haybaeck J: Long non-coding RNAs in endometrial carcinoma. Int
J Mol Sci. 16:26463–26472. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Vallone C, Rigon G, Gulia C, Baffa A,
Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, et
al: Non-coding RNAs and endometrial cancer. Genes (Basel).
9:1872018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Tanos V, Ariel I, Prus D, De-Groot N and
Hochberg A: H19 and IGF2 gene expression in human normal,
hyperplastic, and malignant endometrium. Int J Gynecol Cancer.
14:521–525. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhang L, Wang DL and Yu P: LncRNA H19
regulates the expression of its target gene HOXA10 in endometrial
carcinoma through competing with miR-612. Eur Rev Med Pharmacol
Sci. 22:4820–4827. 2018.PubMed/NCBI
|
|
74
|
Zhao L, Li Z, Chen W, Zhai W, Pan J, Pang
H and Li X: H19 promotes endometrial cancer progression by
modulating epithelial-mesenchymal transition. Oncol Lett.
13:363–369. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ahmed ZSO, Golovoy M, Abdullah Y, Ahmed
RSI and Dou QP: Repurposing of metformin for cancer therapy:
Updated patent and literature review. Recent Pat Anticancer Drug
Discov. 16:161–186. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yan L, Zhou J, Gao Y, Ghazal S, Lu L,
Bellone S, Yang Y, Liu N, Zhao X, Santin AD, et al: Regulation of
tumor cell migration and invasion by the H19/let-7 axis is
antagonized by metformin-induced DNA methylation. Oncogene.
34:3076–3084. 2015. View Article : Google Scholar
|
|
77
|
Lu YM, Wang Y, Liu SQ, Zhou MY and Guo YR:
Profile and validation of dysregulated long non-coding RNAs and
mRNAs in ovarian cancer. Oncol Rep. 40:2964–2976. 2018.PubMed/NCBI
|
|
78
|
Lou Y, Jiang H, Cui Z, Wang X, Wang L and
Han Y: Gene microarray analysis of lncRNA and mRNA expression
profiles in patients with high-grade ovarian serous cancer. Int J
Mol Med. 42:91–104. 2018.PubMed/NCBI
|
|
79
|
Zhong Y, Gao D, He S, Shuai C and Peng S:
Dysregulated expression of long noncoding RNAs in ovarian cancer.
Int J Gynecol Cancer. 26:1564–1570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ren C, Li X, Wang T, Wang G, Zhao C, Liang
T, Zhu Y, Li M, Yang C, Zhao Y and Zhang GM: Functions and
mechanisms of long noncoding RNAs in ovarian cancer. Int J Gynecol
Cancer. 25:566–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Xu J, Wu J, Fu C, Teng F, Liu S, Dai C,
Shen R and Jia X: Multidrug resistant lncRNA profile in
chemotherapeutic sensitive and resistant ovarian cancer cells. J
Cell Physiol. 233:5034–5043. 2018. View Article : Google Scholar
|
|
82
|
Chen CL, Ip SM, Cheng D, Wong LC and Ngan
HY: Loss of imprinting of the IGF-II and H19 genes in epithelial
ovarian cancer. Clin Cancer Res. 6:474–479. 2000.PubMed/NCBI
|
|
83
|
Zhu Z, Song L, He J, Sun Y, Liu X and Zou
X: Ectopic expressed long non-coding RNA H19 contributes to
malignant cell behavior of ovarian cancer. Int J Clin Exp Pathol.
8:10082–10091. 2015.PubMed/NCBI
|
|
84
|
Li J, Huang Y, Deng X, Luo M, Wang X, Hu
H, Liu C and Zhong M: Long noncoding RNA H19 promotes transforming
growth factor-β-induced epithelial-mesenchymal transition by acting
as a competing endogenous RNA of miR-370-3p in ovarian cancer
cells. Onco Targets Ther. 11:427–440. 2018. View Article : Google Scholar :
|
|
85
|
Tian X, Zuo X, Hou M, Li C and Teng Y:
LncRNA-H19 regulates chemoresistance to carboplatin in epithelial
ovarian cancer through microRNA-29b-3p and STAT3. J Cancer.
12:5712–5722. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Sajadpoor Z, Amini-Farsani Z, Teimori H,
Shamsara M, Sangtarash MH, Ghasemi-Dehkordi P and Yadollahi F:
Valproic acid promotes apoptosis and cisplatin sensitivity through
downregulation of H19 noncoding RNA in ovarian A2780 cells. Appl
Biochem Biotechnol. 185:1132–1144. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zheng X, Zhou Y, Chen W, Chen L, Lu J, He
F, Li X and Zhao L: Ginsenoside 20(S)-Rg3 prevents PKM2-targeting
miR-324-5p from H19 sponging to antagonize the warburg effect in
ovarian cancer cells. Cell Physiol Biochem. 51:1340–1353. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hansen S, Sverrisdóttir UÁ and Rudnicki M:
Impact of exercise on pain perception in women with endometriosis:
A systematic review. Acta Obstet Gynecol Scand. 100:1595–1601.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Liu S, Xin W, Lu Q, Tang X, Wang F, Shao
W, Zhang Y, Qiu J and Hua K: Knockdown of lncRNA H19 suppresses
endometriosis in vivo. Braz J Med Biol Res. 54:e101172021.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Panir K, Schjenken JE, Robertson SA and
Hull ML: Non-coding RNAs in endometriosis: A narrative review. Hum
Reprod Update. 24:497–515. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Cui D, Ma J, Liu Y, Lin K, Jiang X, Qu Y,
Lin J and Xu K: Analysis of long non-coding RNA expression profiles
using RNA sequencing in ovarian endometriosis. Gene. 673:140–148.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wu J, Huang H, Huang W, Wang L, Xia X and
Fang X: Analysis of exosomal lncRNA, miRNA and mRNA expression
profiles and ceRNA network construction in endometriosis.
Epigenomics. 12:1193–1213. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Wang Y, Li Y, Yang Z, Liu K and Wang D:
Genome-wide microarray analysis of long non-coding RNAs in eutopic
secretory endometrium with endometriosis. Cell Physiol Biochem.
37:2231–2245. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Wang WT, Sun YM, Huang W, He B, Zhao YN
and Chen YQ: Genome-wide long non-coding RNA analysis identified
circulating LncRNAs as novel non-invasive diagnostic biomarkers for
gynecological disease. Sci Rep. 6:233432016. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Lin D, Huang Q, Wu R, Dai S, Huang Z, Ren
L, Huang S and Chen Q: Long non-coding RNA AFAP1-AS1 promoting
epithelial-mesenchymal transition of endometriosis is correlated
with transcription factor ZEB1. Am J Reprod Immunol. 81:e130742019.
View Article : Google Scholar
|
|
96
|
Liu H, Zhang Z, Xiong W, Zhang L, Du Y,
Liu Y and Xiong X: Long non-coding RNA MALAT1 mediates
hypoxia-induced pro-survival autophagy of endometrial stromal cells
in endometriosis. J Cell Mol Med. 23:439–452. 2019. View Article : Google Scholar
|
|
97
|
Liu J, Wang Q, Zhang R, Zhang C, Lin J and
Huang X: Identification of LINC01279 as a cell cycle-associated
long non-coding RNA in endometriosis with GBA analysis. Mol Med
Rep. 18:3850–3858. 2018.PubMed/NCBI
|
|
98
|
Huan Q, Cheng SC, Du ZH, Ma HF and Li C:
LncRNA AFAP1-AS1 regulates proliferation and apoptosis of
endometriosis through activating STAT3/TGF-β/Smad signaling via
miR-424-5p. J Obstet Gynaecol Res. 47:2394–2405. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Liu S, Qiu J, Tang X, Cui H, Zhang Q and
Yang Q: LncRNA-H19 regulates cell proliferation and invasion of
ectopic endometrium by targeting ITGB3 via modulating miR-124-3p.
Exp Cell Res. 381:215–222. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Xu Z, Zhang L, Yu Q, Zhang Y, Yan L and
Chen ZJ: The estrogen-regulated lncRNA H19/miR-216a-5p axis alters
stromal cell invasion and migration via ACTA2 in endometriosis. Mol
Hum Reprod. 25:550–561. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Liu S, Xin W, Tang X, Qiu J, Zhang Y and
Hua K: LncRNA H19 overexpression in endometriosis and its utility
as a novel biomarker for predicting recurrence. Reprod Sci.
27:1687–1697. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Liu Z, Liu L, Zhong Y, Cai M, Gao J, Tan
C, Han X, Guo R and Han L: LncRNA H19 over-expression inhibited
Th17 cell differentiation to relieve endometriosis through
miR-342-3p/IER3 pathway. Cell Biosci. 9:842019. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Wang Y, Hu T, Wu L, Liu X, Xue S and Lei
M: Identification of non-coding and coding RNAs in porcine
endometrium. Genomics. 109:43–50. 2017. View Article : Google Scholar
|
|
104
|
Wang Y, Hua R, Xue S, Li W, Wu L, Kang T
and Lei M: mRNA/lncRNA expression patterns and the function of
fibrinogen-like protein 2 in Meishan pig endometrium during the
preimplantation phases. Mol Reprod Dev. 86:354–369. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Chen MY, Liao GD, Zhou B, Kang LN, He YM
and Li SW: Genome-wide profiling of long noncoding RNA expression
patterns in women with repeated implantation failure by RNA
sequencing. Reprod Sci. 26:18–25. 2019. View Article : Google Scholar
|
|
106
|
Huang J, Song N, Xia L, Tian L, Tan J,
Chen Q, Zhu J and Wu Q: Construction of lncRNA-related competing
endogenous RNA network and identification of hub genes in recurrent
implantation failure. Reprod Biol Endocrinol. 19:1082021.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Feng C, Shen JM, Lv PP, Jin M, Wang LQ,
Rao JP and Feng L: Construction of implantation failure related
lncRNA-mRNA network and identification of lncRNA biomarkers for
predicting endometrial receptivity. Int J Biol Sci. 14:1361–1377.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Ariel I, Weinstein D, Voutilainen R,
Schneider T, Lustig-Yariv O, de Groot N and Hochberg A: Genomic
imprinting and the endometrial cycle. The expression of the
imprinted gene H19 in the human female reproductive organs. Diagn
Mol Pathol. 6:17–25. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Korucuoglu U, Biri AA, Konac E, Alp E,
Onen IH, Ilhan MN, Turkyilmaz E, Erdem A, Erdem M and Menevse S:
Expression of the imprinted IGF2 and H19 genes in the endometrium
of cases with unexplained infertility. Eur J Obstet Gynecol Reprod
Biol. 149:77–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Zeng H, Fan X and Liu N: Expression of H19
imprinted gene in patients with repeated implantation failure
during the window of implantation. Arch Gynecol Obstet.
296:835–839. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Wang H, Cao Q, Ge J, Liu C, Ma Y, Meng Y,
Wang Y, Zhao X, Liu R, Li C, et al: LncRNA-regulated infection and
inflammation pathways associated with pregnancy loss: Genome wide
differential expression of lncRNAs in early spontaneous abortion.
Am J Reprod Immunol. 72:359–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
He D, Zeng H, Chen J, Xiao L, Zhao Y and
Liu N: H19 regulates trophoblastic spheroid adhesion by
competitively binding to let-7. Reproduction. 157:423–430. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Hu L, Zeng H and Liu N: Expression of H19
long non-coding RNA and ZEB1 in the trophoblast of women with
spontaneous abortion. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
43:179–183. 2018.In Chinese. PubMed/NCBI
|
|
114
|
Bai RX and Tang ZY: Long non-coding RNA
H19 regulates Bcl-2, Bax and phospholipid hydroperoxide glutathione
peroxidase expression in spontaneous abortion. Exp Ther Med.
21:412021. View Article : Google Scholar
|
|
115
|
Li J, Han T, Wang X, Wang Y, Chen X, Chen
W and Yang Q: H19 may regulate the immune cell infiltration in
carcinogenesis of gastric cancer through miR-378a-5p/SERPINH1
signaling. World J Surg Oncol. 20:2952022. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Sahin Y: LncRNA H19 is a potential
biomarker and correlated with immune infiltration in thyroid
carcinoma. Clin Exp Med. 23:841–851. 2023. View Article : Google Scholar
|
|
117
|
Chen X, Luo X, Wei Y, Sun H, Dai L,
Tangzhou Y, Jin H and Yin Z: LncRNA H19 induces immune
dysregulation of BMMSCs, at least partly, by inhibiting IL-2
production. Mol Med. 27:612021. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Li X, Wang H, Zhang Y, Zhang J, Qi S,
Zhang Y and Gao MQ: Overexpression of lncRNA H19 changes basic
characteristics and affects immune response of bovine mammary
epithelial cells. PeerJ. 7:e67152019. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Yang S, Fang F, Yu X, Yang C, Zhang X,
Wang L, Zhu L, Shao K and Zhu T: Knockdown of H19 inhibits the
pathogenesis of acne vulgaris by targeting the miR-196a/TLR2/NF-κB
axis. Inflammation. 43:1936–1947. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Wang B, Suen CW, Ma H, Wang Y, Kong L, Qin
D, Lee YWW and Li G: The roles of H19 in regulating inflammation
and aging. Front Immunol. 11:5796872020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Hashemi M, Moosavi MS, Abed HM, Dehghani
M, Aalipour M, Heydari EA, Behroozaghdam M, Entezari M,
Salimimoghadam S, Gunduz ES, et al: Long non-coding RNA (lncRNA)
H19 in human cancer: From proliferation and metastasis to therapy.
Pharmacol Res. 184:1064182022. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Ye Y, Shen A and Liu A: Long non-coding
RNA H19 and cancer: A competing endogenous RNA. Bull Cancer.
106:1152–1159. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Alipoor B, Parvar SN, Sabati Z, Ghaedi H
and Ghasemi H: An updated review of the H19 lncRNA in human cancer:
Molecular mechanism and diagnostic and therapeutic importance. Mol
Biol Rep. 47:6357–6374. 2020. View Article : Google Scholar : PubMed/NCBI
|
